Literature DB >> 22165705

[Pharmacotherapy following myocardial infarction].

L Spinarová1, J Spinar, J Vítovec.   

Abstract

Early reperfusion is the treatment of choice for acute coronary syndrome. In the Czech Republic, reperfusion therapy is well accessible thanks to the network of 22 catheterization centres. Every year, 28,000 patients are treated using this technique. Successful reperfusion should be followed by life style changes--smoking cessation, maintenance of appropriate body weight etc. These steps than has to be accompanied by effective pharmacotherapy to prevent remodelling of the left ventricle, re-stenosis of the coronary artery, re-thrombosis and arrhythmias. Four drug groups provide the desired effects--renin-angiotensin-aldosterone system blockers, beta-blockers, antiplatelet agents and statins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22165705

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  1 in total

1.  Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.

Authors:  Renata Aiglova; Milos Taborsky; Marie Lazarova; Ludek Pavlu; Josef Danek; Jan Precek; Alexander Schee; Vit Gloger; Vlastimil Cernicek; Marek Vicha; Tomas Skala
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-06-04       Impact factor: 1.648

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.